Hear industry perspectives from expert panelists in our on-demand webinar presentations about optimizing the measurement of cognition.

Increasing the Precision of Cognitive Endpoints in Schizophrenia Clinical Trials

February 13, 2017

Featured Speaker: Paul Maruff – Chief Science Officer, Cogstate Cognitive impairment associated with schizophrenia (CIAS) is an important treatment target, and major unmet therapeutic need in the chronic stages of schizophrenia. Many studies have sought to ameliorate CIAS with new drugs but, as yet, no drug has been approved for treatment of CIAS. In acute […]

Optimizing CNS Endpoints Using Technology-enabled Workflows

November 16, 2016

The integrated rater experience: innovations in eLearning for rater training, eSource data capture and smarter central review Featured Speakers: Pamela Bynum – Learning & Operational Excellence Director, Cogstate Daniella Mulder – Senior Director of Project Management, Clinical Ink Lisle Kingery, PhD – Clinical Science Director, Cogstate A principal challenge in CNS clinical trials are the […]

The Preclinical Alzheimer Cognitive Composite: From Theory to Practical Application in Global Clinical Trials

September 6, 2016

Featured Speakers: Paul Maruff – Chief Science Officer Edward Bartolic – Senior Science Director Drug development strategies for early Alzheimer’s disease require clinical endpoints that are sensitive to the subtlest cognitive changes that may be occurring at even preclinical stages. The Alzheimer’s Disease Cooperative Study- Preclinical Alzheimer Cognitive Composite (ADCS-PACC), is based on retrospective analyses […]